Company History

Biocare Medical was founded in the summer of 1997 by the present owners of the company
Roy Paxton Yih-CEO, Gene Castagnini-CFO, and Dr. David Tacha – Chief Scientific Officer.

2000

  • Patented Antigen Retrieval (Decloaking) Chamber launched

2003

  • Mach Series Polymer Detection & Multiplex IHC Antibody line launched

2006

  • Simultaneous Multiplex IHC technology –patent pending- PIN-4

2007

  • 3000 Decloaking Chambers sold
  • Rabbit Monoclonal capability
  • Fluorescent signal amplification with Mach Series Detection launched

2008

  • intelliPATH FLX™ and SPOT-Light® HER2 CISH launched

2009

  • 19 New Antibodies with 2 New Multiplex IHC products – URO-3 (Bladder) and ADH-5 (Breast)

2010

  • 15 New Antibodies with 4 New Multiplex IHC products – CD4/CD8, GPC3/CK19, TTF1/Napsin A, P63/CK5
  • RISH – in situ hybridization simplified (MRNA) Launched